Phase II study of lapatinib in combination with ErbB2-amplified recurrent or metastatic breast cancer (Turkish Oncology Group Trial) (Abstract No: e13079) J Clin Oncol 29 (suppl)
Copy For Citation
KARACA H.
Annual Meeting of American Society of Clinical Oncology, United States Of America, 1 - 04 January 2011, pp.1
-
Publication Type:
Conference Paper / Full Text
-
Country:
United States Of America
-
Page Numbers:
pp.1
-
Erciyes University Affiliated:
Yes